Internet-based MOTOmed Exercise to Reduce Spasticity and Improve Physical Function in Persons With Multiple Sclerosis

Sponsor
University of Erlangen-Nürnberg (Other)
Overall Status
Completed
CT.gov ID
NCT03548974
Collaborator
Fa. Reck MOTOmed (Other)
57
2
9

Study Details

Study Description

Brief Summary

In an RCT, the effect of the MOTOmed movement trainer (Reck, Germany) on spasticity and physical function in pwMS with EDSS score between 4,5 and 7 is investigated. All subjects exercise at home and are supervised and supported by an exercise therapist via an online platform.

We compare the effect of a 12 week passive, motor-driven movement therapy (VG1) to an intermittent active and passive training (VG2). After 12 weeks, VG1 continues with an active training including strengthening exercises for another 12 weeks. VG2 does not receive any intervention in the second study phase.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Treatment group 1
  • Behavioral: Treatment group 2
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
57 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Internet-based Physical Activity Promotion Using the MOTOmed Movement Trainer to Reduce Spasticity and Improve Physical Function in Moderately to Severely Affected Persons With Multiple Sclerosis
Study Start Date :
Jan 1, 2015
Actual Primary Completion Date :
Oct 1, 2015
Actual Study Completion Date :
Oct 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Interventiongroup1

passive, motor-driven movement therapy followed by intermittent active and passive training

Behavioral: Treatment group 1
The ms-intakt/MOTOmed-intervention is a home-based program using the MOTOmed movement trainer: 12 week passive, motor-driven movement therapy followed by 12 weeks of intermittent active and passive training after the 3month assessment. Training intensity was regulated by the participant's subjective, perceived exertion, which was rated between 6 and 20 on the BORG Scale. Therapists aimed at eliciting a BORG Feedback of between 10 (fairly light) and 15 (hard). The exercise training was home-based and supervised via the internet.

Active Comparator: Interventiongroup2

intermittent active and passive training followed by no intervention

Behavioral: Treatment group 2
The subjects assigned to interventiongroup2 started with 12 weeks intermittent active and passive training followed by 12 weeks of no intervention (Wash out phase)

Outcome Measures

Primary Outcome Measures

  1. Change in spasticity: MSSS-88 [Assessments took place at baseline, at 3 and 6 months]

    This questionnaire contains 88 items, which represent the impairment by the spasticity in various subscales. The total score ranges from 88 to a maximum of 352 points (maximum impairment).

  2. Change in sSpasticity: Modified Tardieu scale [Assessments took place at baseline, at 3 and 6 months]

    The scale is measuring spasticity as response to passive movement at both slow and fast speed; scored 0 - 4. (0=no resistance; 4= inexhaustible clonus)

Secondary Outcome Measures

  1. Change in function: 5-Chair-Rise [Assessments took place at baseline, at 3 and 6 months]

    The main task in this test is to get up and sit down 5 times as fast as possible without use of the arms. The goal is the global assessment of the strength of the lower limb.

  2. Change in function: 25foot-walk-test [Assessments took place at baseline, at 3 and 6 months]

    The task is to walk a 25foot distance as fast as possible. This test measures the functionality of the lower extremity and the walking speed.

  3. Change in function: 2min-walk [Assessments took place at baseline, at 3 and 6 months]

    The subject is asked to walk with the fastest, possible speed to cover the greatest possible distance in 2min.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

diagnosed Multiple Sclerosis (McDonald criteria) EDSS score between 5,5 and 7 diagnosed spasticity access to the internet

Exclusion Criteria:

lack of medical certificate for physical activity cognitive impairment clinically relevant internal disease, especially cardiovascular or pulmonary disease, metabolic and orthopedic diseases

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Erlangen-Nürnberg
  • Fa. Reck MOTOmed

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Prof. Dr. Klaus Pfeifer, Prof. Dr., University of Erlangen-Nürnberg
ClinicalTrials.gov Identifier:
NCT03548974
Other Study ID Numbers:
  • ATRT-2015
First Posted:
Jun 7, 2018
Last Update Posted:
Jun 7, 2018
Last Verified:
May 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Keywords provided by Prof. Dr. Klaus Pfeifer, Prof. Dr., University of Erlangen-Nürnberg
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 7, 2018